SAM
NBIX icon

Sectoral Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$372K Buy
2,960
+55
+2% +$6.91K 0.25% 75
2025
Q1
$321K Sell
2,905
-8,895
-75% -$984K 0.25% 61
2024
Q4
$1.61M Sell
11,800
-715
-6% -$97.6K 1.08% 25
2024
Q3
$1.44M Buy
12,515
+8,580
+218% +$989K 0.85% 37
2024
Q2
$542K Sell
3,935
-260
-6% -$35.8K 0.22% 63
2024
Q1
$579K Sell
4,195
-250
-6% -$34.5K 0.23% 65
2023
Q4
$586K Buy
4,445
+410
+10% +$54K 0.25% 70
2023
Q3
$454K Buy
4,035
+575
+17% +$64.7K 0.09% 108
2023
Q2
$326K Buy
3,460
+660
+24% +$62.2K 0.05% 112
2023
Q1
$283K Hold
2,800
0.05% 110
2022
Q4
$334K Sell
2,800
-250
-8% -$29.9K 0.06% 110
2022
Q3
$324K Hold
3,050
0.06% 97
2022
Q2
$297K Buy
+3,050
New +$297K 0.06% 101
2020
Q3
Sell
-14,100
Closed -$1.72M 148
2020
Q2
$1.72M Buy
+14,100
New +$1.72M 0.16% 83
2018
Q4
Sell
-6,803
Closed -$836K 124
2018
Q3
$836K Buy
+6,803
New +$836K 0.09% 74
2018
Q2
Sell
-111,402
Closed -$9.24M 72
2018
Q1
$9.24M Sell
111,402
-30,900
-22% -$2.56M 1.01% 38
2017
Q4
$11M Sell
142,302
-90,300
-39% -$7.01M 1.38% 28
2017
Q3
$14.3M Sell
232,602
-6,105
-3% -$374K 1.84% 28
2017
Q2
$11M Sell
238,707
-612,312
-72% -$28.2M 1.2% 30
2017
Q1
$36.8M Buy
851,019
+102,031
+14% +$4.42M 4.3% 4
2016
Q4
$29M Sell
748,988
-53,991
-7% -$2.09M 3.21% 12
2016
Q3
$40.7M Sell
802,979
-209,227
-21% -$10.6M 3.99% 7
2016
Q2
$46M Sell
1,012,206
-637,757
-39% -$29M 4.75% 1
2016
Q1
$65.3M Buy
1,649,963
+1,233,283
+296% +$48.8M 3.16% 11
2015
Q4
$23.6M Buy
+416,680
New +$23.6M 1.01% 29